Hospital

EC Healthcare and Yoho Group Form Strategic Partnership

Retrieved on: 
Thursday, June 30, 2022 - 3:06am

HONG KONG, June 30, 2022 - (ACN Newswire) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that the Group signed a memorandum of understanding with Yoho Group Holdings Limited ("Yoho Group", SEHK stock code: 2347) for a strategic collaboration.

Key Points: 
  • HONG KONG, June 30, 2022 - (ACN Newswire) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that the Group signed a memorandum of understanding with Yoho Group Holdings Limited ("Yoho Group", SEHK stock code: 2347) for a strategic collaboration.
  • The partnership will strengthen ECH's online presence in Hong Kong and expand its customer base and further consolidate the leading market position.
  • Under the collaboration, (i) The Group will become Yoho Group's anchor merchant in beauty and healthcare services and Yoho Group will launch an online medical, aesthetic medical and beauty and wellness service zone.
  • Mr. Gemini Wong, Executive Director, Chief Digital Officer and Deputy Marketing Officer of EC Healthcare said, "The Group is delighted to establish a strategic partnership with Yoho Group.

Discovery Behavioral Health Appoints David Semanco as Program Director for New Life Treatment Center in Maryland

Retrieved on: 
Wednesday, June 29, 2022 - 11:07pm

LOS ANGELES, June 29, 2022 /PRNewswire/ -- Discovery Behavioral Health, Inc ., an expanding network of evidence-based mental health, substance use and eating disorder treatment centers, has appointed David Semanco as Program Director of New Life Addiction Counseling & Mental Health Services inPasadena, Maryland, just outside of Annapolis.

Key Points: 
  • LOS ANGELES, June 29, 2022 /PRNewswire/ -- Discovery Behavioral Health, Inc ., an expanding network of evidence-based mental health, substance use and eating disorder treatment centers, has appointed David Semanco as Program Director of New Life Addiction Counseling & Mental Health Services inPasadena, Maryland, just outside of Annapolis.
  • Semanco is a Master Addiction Counselor specializing in the application of complementary therapies to enhance the addiction treatment and recovery process.
  • He transitioned into the addiction treatment field in 2002 following successful careers in information technology and music.
  • He continues to incorporate technology and music into clinical practice as evidenced by his work with neurofeedback and music therapy.

Merit Medical Celebrates Completion of Xeriscape Landscaping Project

Retrieved on: 
Wednesday, June 29, 2022 - 10:30pm

SOUTH JORDAN, Utah, June 29, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today celebrated the completion of a xeriscape landscaping project at its South Jordan headquarters with Utah Governor Spencer J. Cox.

Key Points: 
  • SOUTH JORDAN, Utah, June 29, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today celebrated the completion of a xeriscape landscaping project at its South Jordan headquarters with Utah Governor Spencer J. Cox.
  • The project included a new drip irrigation system designed to prevent water evaporation and runoff.
  • Merit takes corporate citizenship seriously, said Fred P. Lampropoulos, Merit Medicals Chairman and CEO.
  • Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc. and its subsidiaries in the United States and other jurisdictions.

Corcept Therapeutics Initiates Rosella – A Pivotal Phase 3 Trial in Recurrent, Platinum-Resistant Ovarian Cancer

Retrieved on: 
Wednesday, June 29, 2022 - 9:05pm

The 20,000 women in the United States and an equal number in Europe with platinum-resistant ovarian cancer have few good treatment options.

Key Points: 
  • The 20,000 women in the United States and an equal number in Europe with platinum-resistant ovarian cancer have few good treatment options.
  • ROSELLA has a planned enrollment of 360 women with recurrent, platinum-resistant ovarian cancer, randomized 1:1 to receive either relacorilant plus nab-paclitaxel or nab-paclitaxel monotherapy.
  • Additional information about ROSELLA and Corcepts Phase 2 trial results can be found at the publications and press releases tabs of www.corcept.com.
  • Corcept is studying relacorilant in a variety of serious disorders, including ovarian and adrenal cancer and Cushings syndrome.

SpartanNash Foundation Hosts In-Store Fundraiser to Benefit Military Heroes

Retrieved on: 
Wednesday, June 29, 2022 - 9:49pm

As part of a commitment to serve those who bravely serve, the SpartanNash Foundation fundraiser will run from June 29 to July 10.

Key Points: 
  • As part of a commitment to serve those who bravely serve, the SpartanNash Foundation fundraiser will run from June 29 to July 10.
  • SpartanNash has consistently been on the patriotic forefront of recognizing and identifying the needs of the military community, added George Lutz, founder and executive director at Honor and Remember.
  • To learn more about the SpartanNash Foundation and its impact, visit spartannash.com/foundation .
  • Committed to fostering a People First culture, the SpartanNash family of Associates is 17,500 strong and growing.

NuVasive Opens Singapore Experience Center for Asia-Pacific region

Retrieved on: 
Wednesday, June 29, 2022 - 9:10pm

SAN DIEGO, June 29, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced the grand opening of its Singapore Experience Center for the Asia-Pacific region, supporting the Company's growth strategy to globalize its business.

Key Points: 
  • "The NuVasive Singapore Experience Center demonstrates our continued global commitment to scale our world-class business in markets like the Asia-Pacific region and support premier surgeon education," said Chris Barry, chief executive officer ofNuVasive.
  • Senior representatives of the American Chamber of Commerce in Singapore will attend the ribbon cutting event to celebrate the grand opening.
  • The center will provide surgeons across the region the opportunity to train and learn from faculty surgeons in Singapore and provide office space for cross-functional support staff to drive business growth.
  • Features of the Singapore Experience Center include:
    Educational training rooms with advanced cameras and streaming capabilities for effective virtual learning.

Hospital at Home Program Helping Cancer Patients and Their Families With Medical and Financial Support Services

Retrieved on: 
Wednesday, June 29, 2022 - 9:00pm

Lauren received an osteosarcoma diagnosis, a type of bone cancer that most commonly occurs in the long bones around the knee.

Key Points: 
  • Lauren received an osteosarcoma diagnosis, a type of bone cancer that most commonly occurs in the long bones around the knee.
  • For many patients, the symptoms of osteosarcoma include pain or swelling in the affected bone and decreased mobility of the affected limb.
  • The medical team reconstructed what was removed during the procedure with prosthetics and muscles from other areas of her body.
  • The Hospital at Home service sends trained nurses to the patient's home for chemotherapy, administering medications, and other supportive therapies.

Elevation Diagnostics Moves to Fitzsimons Innovation Community Campus in Aurora, Colorado

Retrieved on: 
Wednesday, June 29, 2022 - 9:00pm

AURORA, Colo., June 29, 2022 (GLOBE NEWSWIRE) -- Elevation Diagnostics LLC announced that they have relocated and expanded their operations to a new, state-of-the-art facility located on the Fitzsimons Innovation Community Campus.

Key Points: 
  • AURORA, Colo., June 29, 2022 (GLOBE NEWSWIRE) -- Elevation Diagnostics LLC announced that they have relocated and expanded their operations to a new, state-of-the-art facility located on the Fitzsimons Innovation Community Campus.
  • "We are very excited to join the Fitzsimons Innovation Community.
  • The Company feels honored and excited to have a presence and be part of The University of Colorado Anschutz Medical Campus.
  • Elevation Diagnostics is very committed to integrating into the Campus and making a very positive and measurable impact on the community as a whole.

SEIU-UHW: Los Angeles City Council Passes $25 Healthcare Worker Minimum Wage

Retrieved on: 
Wednesday, June 29, 2022 - 7:21pm

Los Angeles, June 29, 2022 (GLOBE NEWSWIRE) -- The Los Angeles City Council has voted 10-0 in favor of a $25 minimum wage for healthcare workers in the city.

Key Points: 
  • Los Angeles, June 29, 2022 (GLOBE NEWSWIRE) -- The Los Angeles City Council has voted 10-0 in favor of a $25 minimum wage for healthcare workers in the city.
  • "We applaud the Los Angeles City Council for leading the way toward protecting public health and addressing a staffing shortage that threatens Angelenos' care," said Dave Regan, president of SEIU-United Healthcare Workers West.
  • "By ensuring healthcare workers earn a fair wage that reflects the vital work they do, Los Angeles can retain and attract the workers needed to ensure the quality of healthcare doesn't decline in the city."
  • The new minimum wage would cover all private sector healthcare workers who work in hospitals, integrated health systems, and dialysis clinics in the city of Los Angeles.

AeroClean Technologies, Inc. Announces Closing of $15.0 Million Private Placement

Retrieved on: 
Wednesday, June 29, 2022 - 7:19pm

PALM BEACH GARDENS, Fla., June 29, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies, Inc. (AeroClean or the Company) (Nasdaq: AERC),announced today the closing of its previously-announced $15.0 million private placement with a single institutional investor.

Key Points: 
  • PALM BEACH GARDENS, Fla., June 29, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies, Inc. (AeroClean or the Company) (Nasdaq: AERC),announced today the closing of its previously-announced $15.0 million private placement with a single institutional investor.
  • The transaction consists of 1,500,000 shares of AeroClean common stock and warrants to purchase up to an aggregate of 1,500,000 shares of common stock.
  • Warrants with respect to approximately 1.26 million shares will become exercisable on the earlier of the effective date of a registration statement related to the transaction or the 90th day following the closing.
  • The Benchmark Company and Roth Capital Partners acted as the exclusive placement agents for the private placement.